| Trial ID: | L0546 |
| Source ID: | JPRN-UMIN000027304
|
| Associated Drug: |
SGLT2 inhibitor
|
| Title: |
A study on the effect of diabetes drugs (SGLT2 inhibitor and DPP4 inhibitor) for nonalcoholic fatty liver disease - A study on the effect of diabetes drugs (SGLT2 inhibitor and DPP4 inhibitor) for nonalcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
Has Results
|
| Results: |
in press
|
| Conditions: |
nonalcoholic fatty liver disease
|
| Interventions: |
For 12 weeks, dapagliflozin 5 mg is administered daily.<br>For 12 weeks, tengliptin 5 mg is administered daily.
|
| Outcome Measures: |
The rate of change of ALT value after 12 weeks from the start of administrationnan
|
| Sponsor/Collaborators: |
Department of Hepatology, Shimane University Hospital
|
| Gender: |
All
|
| Age: |
20years-old80years-old
|
| Phases: |
Not selected
|
| Enrollment: |
20
|
| Study Type: |
Interventional
|
| Study Designs: |
Parallel Randomized
|
| Start Date: |
15/05/2017
|
| Completion Date: |
06/04/2018
|
| Results First Posted: |
13/11/2020
|
| Last Update Posted: |
17 May 2021
|
| Locations: |
Japan
|
| URL: |
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031263
|
